Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®

Author： Italia J.   Yahya M.   Singh D.   Ravi Kumar M.  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.26, Iss.6, 2009-06, pp. : 1324-1331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differences in human phospholipid transfer protein activity following incubation of Fungizone® compared to lipid-based Amphotericin-B formulations in normolipidemic and hyperlipidemic plasma

By Henderson Ryan J.   Leon Carlos G.   Wasan Kishor M.  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 9, 2009-09 ,pp. : 1139-1146

Informa Healthcare

Access to resources Recommend Favorite

Amphotericin B: Nephrotoxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1379, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Fungizone (amphotericin B) labelling is being revised in the UK to warn of the risks of overdose

By  

Reactions Weekly, Vol. 1, Iss. 1298, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Development of Biodegradable Nanoparticles for Oral Delivery of Ellagic Acid and Evaluation of Their Antioxidant Efficacy Against Cyclosporine A-Induced Nephrotoxicity in Rats

By Sonaje K.   Italia J.   Sharma G.   Bhardwaj V.   Tikoo K.   Kumar M.  

Pharmaceutical Research, Vol. 24, Iss. 5, 2007-05 ,pp. : 899-908

Springer Publishing Company

Access to resources Recommend Favorite

Oral Bioavailability and Stability Study of a Self-Emulsifying Drug Delivery System (SEDDS) of Amphotericin B

By  

Current Drug Delivery, Vol. 10, Iss. 5, 2013-10 ,pp. : 542-547

Bentham Science Publishers

Access to resources Recommend Favorite